Clinical Trials Browser

Phase 1 × Not yet recruiting × Neoplasms × Clear all

NCT07476326 2026-03-17

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

Phase 1 Not yet recruiting

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms

NCT07454031 2026-03-13

Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma

Phase 1 Not yet recruiting

Neoplasm Metastasis, Neoplasms

NCT07462468 2026-03-13

A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.

Phase 1 Not yet recruiting

Neoplasms, Ovarian Neoplasms

NCT07454668 2026-03-06

Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases

Phase 1 Not yet recruiting

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT07224776 2026-02-27

Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria

Phase 1 Not yet recruiting

Neoplasms, Proteinuria

NCT07438782 2026-02-27

First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors

Phase 1 Not yet recruiting

Neoplasms

NCT07409246 2026-02-13

A Study to Evaluate the, Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

Phase 1 Not yet recruiting

Multiple Myeloma, Neoplasms

NCT07368127 2026-01-26

A Study of TPD3310 in Patients With Advanced Malignant Tumors

Phase 1 Not yet recruiting

Neoplasms

NCT05544968 2026-01-12

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Neoplasms, Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT07054944 2025-12-15

T-LyM

Phase 1 Not yet recruiting

Neoplasms, Neoplasms, Germ Cell and Embryonal, Rhabdomyosarcoma, Sarcoma

NCT07192471 2025-09-25

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Phase 1 Not yet recruiting

DermatologicLymphoid

Immune System Diseases, Lymphoma, Mycosis Fungoides, Neoplasms, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT07144085 2025-08-27

Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.

Phase 1 Not yet recruiting

Neoplasm Metastasis, Neoplasms

NCT07057349 2025-07-09

CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer

Phase 1 Not yet recruiting

Neoplasm Metastasis, Neoplasms

NCT07053735 2025-07-08

An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer

Phase 1 Not yet recruiting

Urinary Bladder Neoplasms, Neoplasms

NCT06956261 2025-05-04

NW-301 TCR-T in Patients With Advanced Solid Tumor

Phase 1 Not yet recruiting

Neoplasms

NCT06389526 2024-09-19

A Study of CHS-1000 in Participants With Advanced or Metastatic Solid Tumors

Phase 1 Not yet recruiting

Neoplasms

NCT06558175 2024-08-16

REPAIR

Phase 1 Not yet recruiting

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Neoplasms

NCT06528249 2024-07-30

Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies

Phase 1 Not yet recruiting

Other hematologic neoplasm

Neoplasms, Hematologic Neoplasms

NCT05361954 2023-04-12

Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors

Phase 1 Not yet recruiting

GastrointestinalSarcoma

Neoplasms, Pancreatic Neoplasms, Sarcoma